An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients

被引：0
|
作者：
Anatole Besarab
Steven N Zeig
Edouard R Martin
Pablo E Pergola
Frederick C Whittier
Raja I Zabaneh
Brigitte Schiller
Martha Mayo
Carol A Francisco
Krishna R Polu
Anne-Marie Duliege
机构：
[1] Henry Ford Hospital,
[2] Pines Clinical Research,undefined
[3] South Florida Nephrology Associates,undefined
[4] Renal Associates PA,undefined
[5] Clinical Research Ltd,undefined
[6] Northwest Louisiana Nephrology,undefined
[7] Satellite Healthcare,undefined
[8] Affymax,undefined
[9] Inc,undefined
来源：
BMC Nephrology | / 13卷
关键词：
Anemia; Chronic kidney disease; Erythropoiesis-stimulating agent; Epoetin alfa; Hemodialysis; Peginesatide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients
    Besarab, Anatole
    Zeig, Steven N.
    Martin, Edouard R.
    Pergola, Pablo E.
    Whittier, Frederick C.
    Zabaneh, Raja I.
    Schiller, Brigitte
    Mayo, Martha
    Francisco, Carol A.
    Polu, Krishna R.
    Duliege, Anne-Marie
    [J]. BMC NEPHROLOGY, 2012, 13
  • [2] Dose-finding Study of Peginesatide for Anemia Correction in Chronic Kidney Disease Patients
    Macdougall, Iain C.
    Wiecek, Andrzej
    Tucker, Beatriz
    Yaqoob, Magdi
    Mikhail, Ashraf
    Nowicki, Michal
    MacPhee, Iain
    Mysliwiec, Michal
    Smolenski, Olgierd
    Sulowicz, Wladyslaw
    Mayo, Martha
    Francisco, Carol
    Polu, Krishna R.
    Schatz, Peter J.
    Duliege, Anne-Marie
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (11): : 2579 - 2586
  • [3] An Open-Label Dose-Finding Study of Allopurinol to Target Defined Reduction in Urate Levels in Hemodialysis Patients
    Rutherford, Elaine
    Stewart, Graham
    Houston, J. Graeme
    Jardine, Alan G.
    Mark, Patrick B.
    Struthers, Allan D.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (11): : 1409 - 1414
  • [4] Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study
    Musa, Ahmed M.
    Younis, Brima
    Fadlalla, Ahmed
    Royce, Catherine
    Balasegaram, Manica
    Wasunna, Monique
    Hailu, Asrat
    Edwards, Tansy
    Omollo, Raymond
    Mudawi, Mahmoud
    Kokwaro, Gilbert
    El-Hassan, Ahmed
    Khalil, Eltahir
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2010, 4 (10)
  • [5] An open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors
    Di Paola, Eugenio Donato
    Alonso, Silvia
    Giuliani, Rosa
    Calabro, Fabio
    DAlessio, Antonietta
    Regine, Giovanni
    Cerbone, Linda
    Bianchi, Laura
    Mancuso, Andrea
    Sperka, Sabine
    Rozencweig, Marcel
    Sternberg, Cora N.
    [J]. FRONTIERS IN ONCOLOGY, 2012, 2
  • [6] Open-label dose-finding trial of buprenorphine implants (Probuphine)® for treatment of heroin dependence
    White, Jason
    Bell, James
    Saunders, John B.
    Williamson, Paul
    Makowska, Maria
    Farquharson, Aaron
    Beebe, Katherine L.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2009, 103 (1-2) : 37 - 43
  • [7] Phase 2 open-label, dose-finding study of intravenous ganaxolone for the treatment of refractory status epilepticus
    Vaitkevicius, Henrikas
    Ramsay, Eugene
    Swisher, Christa B.
    Husain, Aatif
    Aimetti, Alex
    Gasior, Maciej
    [J]. EPILEPSIA, 2021, 62 : 348 - 348
  • [8] Dose-Finding Study of Rivaroxaban in Hemodialysis Patients
    De Vriese, An S.
    Caluwe, Rogier
    Bailleul, Els
    De Bacquer, Dirk
    Borrey, Danielle
    Van Vlem, Bruno
    Vandecasteele, Stefaan J.
    Emmerechts, Jan
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (01) : 91 - 98
  • [9] An open-label phase I dose-finding study of APR-246 in hematological malignancies
    Deneberg, S.
    Cherif, H.
    Lazarevic, V.
    Andersson, P-O
    von Euler, M.
    Juliusson, G.
    Lehmann, S.
    [J]. BLOOD CANCER JOURNAL, 2016, 6 : e447 - e447
  • [10] An open-label phase I dose-finding study of APR-246 in hematological malignancies
    S Deneberg
    H Cherif
    V Lazarevic
    P-O Andersson
    M von Euler
    G Juliusson
    S Lehmann
    [J]. Blood Cancer Journal, 2016, 6 : e447 - e447
12345